cyproterone acetate has been researched along with Adenoma, Prostatic in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (48.00) | 18.7374 |
| 1990's | 10 (40.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abo-El-Enen, M; El-Gamal, OM; El-Hitham, AA; El-Rasheedy, M; Elbendary, MA; Gameel, TA; Ghoneem, A; Sabaa, M; Soliman, MG | 1 |
| Assinder, SJ; Nicholson, HD | 1 |
| Neumann, F; Schenck, B; Senge, T; Tunn, U | 1 |
| Neumann, F; Ruberg, I; Senge, T | 1 |
| Bartsch, G; Daxenbichler, G; Rohr, HP | 1 |
| Pachman, A | 1 |
| Di Federico, G; Iantorno, R; Lombardi, G; Nicolai, M; Tenaglia, R; Zezza, A | 1 |
| Buscarini, M; D'Eramo, G; Di Silverio, F; Flammia, GP; Frascaro, E; Mariani, M; Sciarra, A | 1 |
| Bartsch, G; Horninger, W | 1 |
| Benassayag, E | 1 |
| Lotti, T; Montironi, R; Polito, M; Prezioso, D | 2 |
| Barbalias, G; Gyftopoulos, K; Markou, S; Perimenis, P | 1 |
| Blom, JH; Bolt-de Vries, J; de Jong, FH; Mulder, E; Reuvers, PJ; Schroeder, FH | 1 |
| Van Cangh, PJ | 1 |
| Braf, Z; Leib, Z; Lindner, A; Saranga, R; Servadio, C; Siegel, Y | 1 |
| Guzzoni, G; Montorsi, F; Rigatti, P | 1 |
| Graff, J; Nieschlag, E; Schürmeyer, T; Senge, T | 1 |
| Rist, M | 1 |
| Bashirelahi, N; Ekiko, DB; Ganesan, S; Shida, K; Takahashi, E; Yamanaka, H; Young, JD | 1 |
| el Etreby, MF; Habenicht, UF | 2 |
| Concolino, G; Conti, C; Di Silverio, F; Lubrano, C; Petrangeli, E; Sciarra, F; Toscano, V | 1 |
| Blom, JH; Bosch, RJ; Griffiths, DJ; Schroeder, FH | 1 |
| Namer, M | 1 |
4 review(s) available for cyproterone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
[Androgen deprivation in benign prostatic hypertrophy].
Topics: Adult; Aged; Androgen Antagonists; Cyproterone Acetate; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Progesterone Congeners; Prostatic Hyperplasia | 1993 |
[Pharmacological combinations in the treatment of benign prostatic hypertrophy].
Topics: Bromocriptine; Cyproterone Acetate; Drug Therapy, Combination; Gestonorone Caproate; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Tamoxifen | 1993 |
[Hormonal therapy of benign prostatic hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Androgen Antagonists; Clinical Trials as Topic; Cyproterone Acetate; Flutamide; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Urodynamics | 1995 |
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Puberty, Precocious; Skin Diseases; Spironolactone | 1988 |
9 trial(s) available for cyproterone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
Perioperative use of cyproterone acetate with transurethral resection of large prostate: preliminary results.
Topics: Androgen Antagonists; Blood Loss, Surgical; Cyproterone Acetate; Humans; Male; Middle Aged; Organ Size; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Prostate; Prostatic Hyperplasia; Transurethral Resection of Prostate | 2015 |
[Pharmacological combinations in the treatment of benign prostatic hypertrophy].
Topics: Bromocriptine; Cyproterone Acetate; Drug Therapy, Combination; Gestonorone Caproate; Humans; Male; Plant Extracts; Prostatic Hyperplasia; Tamoxifen | 1993 |
[Indications of antiandrogens in benign hyperplasia of the prostate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Prostatic Hyperplasia | 1995 |
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian Group.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyproterone Acetate; Delayed-Action Preparations; Diagnosis, Differential; Disease-Free Survival; Drug Administration Schedule; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms | 1998 |
Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Diagnosis, Differential; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 1999 |
Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Finasteride; Hematuria; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Recurrence | 2002 |
[Current therapy of benign prostatic hypertrophy].
Topics: Adult; Aged; Androgen Antagonists; Bromocriptine; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Humans; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia | 1986 |
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
Topics: Androgen Antagonists; Anilides; Cell Nucleus; Cyproterone; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Flutamide; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Tamoxifen | 1988 |
Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Humans; Male; Prospective Studies; Prostate; Prostatic Hyperplasia; Random Allocation; Ultrasonography; Urodynamics | 1989 |
13 other study(ies) available for cyproterone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
Effects of steroids on oxytocin secretion by the human prostate in vitro.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Animals; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Oxytocin; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Rats; Testosterone; Time Factors | 2004 |
Effects of cyproterone acetate on experimentally induced canine prostatic hyperplasia. A morphological and histochemical study.
Topics: Acid Phosphatase; Aminopeptidases; Androstanols; Animals; Castration; Cyproterone; Cyproterone Acetate; Disease Models, Animal; Dogs; Estradiol; Male; Prostatic Hyperplasia; Zinc | 1980 |
Microautoradiographic studies on distribution of 5 alpha-dihydrotestosterone, cyproterone acetate and oestradiol-17 beta in human prostatic hyperplasia tissue transplanted to juvenile rats.
Topics: Aged; Animals; Autoradiography; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estradiol; Humans; Male; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred Strains; Silver; Staining and Labeling; Transplantation, Heterologous | 1982 |
4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
Topics: Androgen Antagonists; Bromocriptine; Cyproterone; Cyproterone Acetate; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Muscle, Smooth; Prolactin; Prostate; Prostatic Hyperplasia; Tamoxifen; Testosterone | 1983 |
Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.
Topics: Adult; Cell Nucleus; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Female; Humans; Male; Pregnancy; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone | 1984 |
Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
Topics: 5-alpha Reductase Inhibitors; Androgens; Binding, Competitive; Cell Nucleus; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone | 1992 |
[Non-surgical treatment of benign prostatic hypertrophy. Current status of the problem].
Topics: Androgen Antagonists; Aromatase Inhibitors; Cholestenone 5 alpha-Reductase; Cyproterone Acetate; Enzyme Inhibitors; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Oxidoreductases; Progestins; Prostatic Hyperplasia | 1992 |
Local thermotherapy of the benign prostate: a 1-year follow-up.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Prostatic Hyperplasia; Time Factors; Urination; Urine; Urodynamics | 1990 |
Local microwave hyperthermia and benign prostatic hyperplasia induced bladder outlet obstruction.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Catheters, Indwelling; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Humans; Hyperthermia, Induced; Male; Microwaves; Middle Aged; Prostatic Hyperplasia; Time Factors; Urinary Bladder Neck Obstruction; Urinary Catheterization; Urination | 1990 |
Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Circadian Rhythm; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Estradiol; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1986 |
Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
Topics: Binding, Competitive; Centrifugation, Density Gradient; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estrenes; Humans; Male; Mathematics; Metribolone; Nandrolone; Norpregnadienes; Promegestone; Prostatic Hyperplasia | 1986 |
Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Cyproterone; Cyproterone Acetate; Dogs; Drug Synergism; Drug Therapy, Combination; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1987 |
Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
Topics: Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Dogs; Epididymis; Luteinizing Hormone; Male; Organ Size; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testis | 1989 |